Cargando...
Dasatinib as a treatment for Duchenne muscular dystrophy
Identification of a systemically acting and universal small molecule therapy for Duchenne muscular dystrophy would be an enormous advance for this condition. Based on evidence gained from studies on mouse genetic models, we have identified tyrosine phosphorylation and degradation of β-dystroglycan a...
Gardado en:
| Publicado en: | Hum Mol Genet |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Oxford University Press
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4706114/ https://ncbi.nlm.nih.gov/pubmed/26604135 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/hmg/ddv469 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|